IITRI NEWS

NEWS

We are ready to answer your questions and provide guidance.

News

SARS-CoV-2 Variants of Concern Now Available

SARS-CoV-2 Variants of Concern Now Available

IITRI now has access to multiple SARS-CoV-2 variants. Currently available: B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma). Available soon: B.1.617.1 (Kappa) and B.1.617.2 (Delta) These variants are available for use in our assays (immunostain and neutralization) as well...

Immunostain SARS-CoV-2 Efficacy Assay Available

Immunostain SARS-CoV-2 Efficacy Assay Available

IITRI now offers an improved efficacy assay for looking at effects of drugs on SARS-CoV-2. Although this assay no longer includes a cytotoxicity readout, we offer a neutral red assay in BSl-2 instead if needed. This current assay uses immunostaining and provides more...

Dave McCormick at Science2Startup: New Sleep Apnea Drugs

Dave McCormick at Science2Startup: New Sleep Apnea Drugs

David McCormick has been selected to present on the development of novel agents to treat sleep-disordered breathing (SDB; sleep apnea) at the invitation-only Science2Startup (S2S)™ symposium on April 23, 2019, in Cambridge. The presenting group of 12 was...